MetaCap

CapsoVision Statistics

NASDAQ: CVHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD

6.11-0.20 (-3.17%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CapsoVision by the numbers

CapsoVision has a market capitalization of $327.6 million based on 53.61M shares outstanding. With trailing EPS of $-0.42, CapsoVision is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 6.5% below its 50-day average and 4.7% below its 200-day average.

Average daily trading volume is 173.59K shares, or about $1.1 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

CV valuation vs. peer median

CV compared with the median of 8 peer companies
MetricCVPeer medianDifference
Market cap$327.56M$94.36M+247%
Avg. volume173.59K188.70K-8%

Peer median across 8 companies: ELMD, FOCL, VANI, STXS, HSDT, NRXS, HYPR, OM.

Valuation

Market cap
$327.56M
Price / sales (latest FY)
24.17
EPS (TTM)
$-0.42

Price and trading

Previous close
6.31
Open
6.26
Day range
6.01 – 6.37
52-week range
4.50 – 15.37
52-week change
+16.83%
Beta
—
Volume
178.65K

Dividends and events

Annual dividend
None
Next earnings date
Nov 12, 2026

Additional statistics

Market Cap
327.56M
Eps
-0.42
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
15.37
Week52 Low
4.50
Avg Volume
173.59K
Shares Outstanding
53.61M
Ma50
6.54
Ma200
6.41
Earnings Date
Nov 12, 2026
Pct From52w High
-60.25%
Pct From52w Low
35.78%

Related